Source:http://linkedlifedata.com/resource/pubmed/id/18785811
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2008-9-12
|
pubmed:abstractText |
The principle of currently available licensed HIV-1 RNA assays is based on real-time technologies that continuously monitor the fluorescence emitted by the amplification products. Besides these assays, in-house quantitative (q) real-time reverse transcription (RT)-PCR (RT-qPCR) tests have been developed and evaluated particularly in developing countries, for two main reasons. First, affordable and generalized access to HIV-1 RNA viral load is urgently needed in the context of expected universal access to prevention and antiretroviral treatment programs in these settings. Second, since many non-B subtypes, circulating recombinant forms and unique recombinant forms circulate in these areas, in-house HIV-1 RNA RT-qPCR assays are ideal academic tools to thoroughly evaluate the impact of HIV-1 genetic diversity on the accuracy of HIV-1 RNA quantification, as compared with licensed techniques. To date, at least 15 distinct in-house assays have been designed. They differ by their chemistry and the HIV-1 target sequence (located in gag, Pol-IN or LTR gene). Analytical performances of the tests that have been extensively evaluated appear at least as good as (or even better than) those of approved assays, with regard to HIV-1 strain diversity. Their clinical usefulness has been clearly demonstrated for early diagnosis of pediatric HIV-1 infection and monitoring of highly active antiretroviral therapy efficacy. The LTR-based HIV-1 RNA RT-qPCR assay has been evaluated by several groups under the auspices of the Agence Nationale de Recherches sur le SIDA et les hépatites virales B et C. It exists now as a complete standardized commercial test.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1744-8352
|
pubmed:author |
pubmed-author:DanaviahSivapragashiniS,
pubmed-author:GanonAmandineA,
pubmed-author:LienTruong XuanTX,
pubmed-author:MénanHervéH,
pubmed-author:MandaliyaKishorK,
pubmed-author:NerrienetEricE,
pubmed-author:Ngo-Giang-HuongNicoleN,
pubmed-author:RouetFrançoisF,
pubmed-author:RoussetDominiqueD,
pubmed-author:ValéaDianeD,
pubmed-author:ViljoenJohannesJ
|
pubmed:issnType |
Electronic
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
635-50
|
pubmed:meshHeading |
pubmed-meshheading:18785811-DNA Primers,
pubmed-meshheading:18785811-Developing Countries,
pubmed-meshheading:18785811-HIV-1,
pubmed-meshheading:18785811-Humans,
pubmed-meshheading:18785811-RNA, Viral,
pubmed-meshheading:18785811-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:18785811-Time Factors
|
pubmed:year |
2008
|
pubmed:articleTitle |
In-house HIV-1 RNA real-time RT-PCR assays: principle, available tests and usefulness in developing countries.
|
pubmed:affiliation |
Laboratoire de Virologie, Centre Muraz, BP390 Bobo-Dioulasso 01, Burkina Faso. franrouet@yahoo.fr
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|